| 1. |
- Nilsson, Doris, 1952-, et al.
(författare)
-
Psychometric properties of the Child and Adolescent Trauma Screen (CATS) in a sample of Swedish children
- 2021
-
Ingår i: Nordic Journal of Psychiatry. - : Informa UK Limited. - 0803-9488 .- 1502-4725. ; 75:4, s. 247-256
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: The aim of this study was to investigate the psychometrics of the Swedish version of the Child and Adolescent Trauma Screen (CATS). This was to obtain access to an international instrument to identify symptoms of post-traumatic stress in children and adolescents according to the new Diagnostic and Statistical Manual for Mental Disorders, 5th edition (DSM-5).METHOD: A total of 591 young Swedish schoolchildren aged 13-17 years old were given the CATS together with the Trauma Symptom Checklist for Children (TSCC), and the Linköping Youth Life Experience Scale (LYLES-Y). A clinical group of 42 children who had experienced a potential trauma was also given the same questionnaires. Statistical analyses were carried out for the purpose of reliability, different kinds of validity, and confirmatory factor analysis (CFA) concerning the construct of the CATS.RESULTS: The CATS showed good internal consistency on all four subscales from α = 0.73-0.89 and moderate stability (intra class correlation [ICC] = 0.57-68). The four-factor model for PTSD indicated good fit, reliability, and convergent validity. The CATS correlated strongly with the PTSD subscale on the TSCC (r = 0.82) and there were significant differences between the nonclinical and clinical groups.CONCLUSIONS: The study shows that the Swedish translation of CATS has satisfactory psychometric properties, including acceptable sensitivity and specificity. The CATS could therefore be used as a screening tool both outside and within a clinical setting.
|
|
| 2. |
- Rajan, Gita, et al.
(författare)
-
Delayed healthcare access among victims of sexual abuse, understood through internal and external gatekeeping mechanisms
- 2021
-
Ingår i: Nordic Journal of Psychiatry. - : Informa UK Limited. - 0803-9488 .- 1502-4725. ; 75:5, s. 370-377
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Sexual abuse is associated with severe health consequences, and the European Union has, through the Istanbul Convention, urged its member countries to provide specialist care for victims of sexual abuse.AIM: This aim of this study was to investigate patient- and abuse-related characteristics among patients seeking help at a specialist clinic in Sweden, with focus on disclosure, mental health and appropriate healthcare access.METHODS: This is a descriptive study where journal data from 100 consecutive patients January 2017 to February 2018 were analyzed. All adult individuals (women n = 80, men n = 8) who had taken part in the standardized semi-structured intake interview at the clinic were included (n = 88).RESULTS: At admission, mean age was 40.3 (SD 11.9), mean number of psychiatric diagnoses 6.3 (2.6), and 93% of the patients scored above cut-off (≥34) on IES-R for PTSD. A majority of the patients (87%) had been exposed to childhood sexual abuse (CSA), and mean time to first disclosure was 15.9 (SD 15.3) years. In total, 82% of the patients had, despite disclosure, experienced difficulties accessing appropriate healthcare before coming to the specialist clinic.CONCLUSION: Adult victims of sexual abuse have difficulties accessing appropriate healthcare. This constitutes a gender-based equality problem. A model of gatekeeping mechanisms with two dimensions (external and internal) and three categories (Competence related, Organizational and Emotional) is proposed to understand these difficulties.
|
|
| 3. |
- Rise, Marit B., et al.
(författare)
-
Patients' perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate : A qualitative interview study
- 2021
-
Ingår i: Nordic Journal of Psychiatry. - : Informa UK Limited. - 0803-9488 .- 1502-4725. ; 75:4, s. 257-265
-
Tidskriftsartikel (refereegranskat)abstract
- INTRODUCTION: Three-monthly dosage of paliperidone palmitate entails longer time to relapse after discontinuation, is similarly tolerable and safe compared to monthly injections of paliperidone palmitate and is beneficial for the caregivers. However, few studies have so far explored in depth the patients' experiences with paliperidone palmitate medication every three months, or with switching from monthly to three-monthly injections of paliperidone palmitate.MATERIAL AND METHODS: A qualitative study based on individual interviews with persons with schizophrenia who receive three-monthly paliperidone palmitate in Norway, Sweden and Denmark. Data was analysed according to qualitative content analysis.RESULTS: Twenty-four patients, 16 men and 8 women, took part in individual interviews. The patients' mental health care professionals mainly recommended the switch to three-monthly paliperidone palmitate, and few or no disadvantages were described. According to the patients, three-monthly paliperidone palmitate had several advantages, such as less frequent injections, less administration and planning and less focus on the illness. In addition, the participants described feeling more stability, being more physically and socially active, and that improvement processes were supported. For some, the use involved practical and economic challenges, and some worried whether the medicine 'wore off' before the next injection. According to the patients, switching to three-monthly paliperidone palmitate did not influence the frequency or content of patients' interaction with health care professionals.CONCLUSION: Switching from monthly to three-monthly injections with paliperidone palmitate seems to be experienced as advantageous for patients with schizophrenia.
|
|
